Genialis Debuts ResponderID for Clinical Biomarker Discovery
Machine Learning-native technology platform focuses on modeling disease biology to better match patients to the most effective therapies BASEL, Switzerland & BOSTON–(BUSINESS WIRE)–#AACR—Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced the launch of ResponderID™, a new AI/ML-enabled platform specifically for use in clinical biomarker discovery. […]


